Geographic expansion is a standard growth strategy in healthcare investing. Companies with a proven model and strong results often seek to replicate that success in new states.
When Medicaid is a major revenue source, that map can be misleading. Medicaid operates under federal guidelines, but each state runs its own program. What works in one state may not work in another, and those differences often determine whether a growth plan succeeds.
Medicaid Is Administered State by State
Nationally, Medicaid is often described as a single program. For investors, that view can be misleading. States vary in care delivery, health plan contracts, provider payment, and priorities.
Two states may look similar in population and demand but offer very different opportunities. The key question isn’t demand, but whether the state’s Medicaid environment supports the company’s strategy.
Market Size Is the Wrong Question
A large Medicaid population may suggest a big opportunity, but size only translates to revenue if the company can access those members under state rules.
This requires understanding how care is delivered, which MCOs control access, and where the company fits among current providers. Enrollment trends are also critical. Knowing which populations are growing or shrinking, and why, reveals more about the real market than headline enrollment numbers. National coverage figures say little about any one state.
Same Federal Framework, Different Buyer
Consider how two large states structure managed care:
In Texas, the state procures MCOs by service area, and most Medicaid members receive care through those plans. Winning business largely means building relationships with the plans the state has selected and understanding how the procurement cycle can reshape that field.
California’s Medi-Cal program organizes managed care differently by county. Some counties use a two-plan model. Others are served by a County Organized Health System, where a single locally governed plan covers the county. A provider with strong plan relationships in one county may find none carry over to the next.
The key difference is the customer. In some markets, states contract with multiple competing plans. In others, a single plan acts as the county’s gatekeeper. This structure shifts contracting strategy, negotiating leverage, and concentration risk, and these factors rarely appear in a financial model based on home-state results.
Reimbursement Assumptions Rarely Travel
Reimbursement is often where expansion models fall short. Projections for new states are usually based on existing economics, but rate methodologies, fee schedules, and payment approaches differ. A service with strong margins in one state may be barely sustainable in another.
Investors should test several questions directly:
- Does projected performance in the new state rely on rates or payment structures observed elsewhere?
- How would a difference in reimbursement change unit economics and margin?
- What policy changes could move those assumptions during the hold period?
Reimbursement and policy factors drive operational performance, growth assumptions, and long-term returns. These should be explicit inputs in the model, not afterthoughts.
Policy Direction Is Part of the Thesis
State priorities, program requirements, and regulations shape Medicaid markets. A growth plan that looks promising today may change after a program redesign, procurement, or rule update.
Policy change is not just a risk. New state priorities create needs, and companies that align with them can benefit. The key diligence question is how market direction fits with the company’s model. Some opportunities move with the market, while others require adaptation or investment.
Stress-Test the Five-State Growth Plan
Suppose a Medicaid-reimbursed behavioral health provider has built a successful model in three states. The investment case assumes entry into five more over the next several years, with revenue scaling accordingly.
Before including that growth in the thesis, test the assumptions behind it:
- Payer mix. Does the company’s revenue depend on a few MCOs in its current state? What does the plan landscape look like in each target state, and does the company already have a relationship with any of those plans?
- Rate methodology. Are the target states’ rates for the same services comparable? If they aren’t, does the model still work?
- Authorization and utilization requirements. Do prior authorization rules, network requirements, or utilization management practices differ in ways that change staffing, workflow, or time to revenue?
Any of these factors can shift a five-state plan from attractive to marginal. The goal is not to label a state as good or bad, but to understand what success would require and whether the company and investor are ready to deliver it.
Local Context Turns Data Into Judgment
Data alone does not answer these questions. Interpreting data requires understanding how Medicaid market participants behave. State agencies, MCOs, providers, and members all have different incentives.
Our team brings that perspective. We include former federal and state program leaders, managed care executives, hospital leaders, health technology innovators, and policy experts who have run these programs. Applied to a specific state, this experience shifts the question from ‘How big is this opportunity?’ to ‘How does this opportunity actually work?’
The Bottom Line
Entering a new Medicaid market can drive growth, but only if diligence treats each state as a distinct market. The payer landscape, reimbursement, regulation, and policy direction can differ from the home market, and any of them can change the return profile.
When Medicaid is part of the investment case, where a company grows matters just as much as how.
Evaluating an acquisition or expansion into a new Medicaid market? Contact Sellers Dorsey to talk through how state-specific program insight can strengthen your diligence.
